Male Breast Cancer

2

Review clinical trials related to Male Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

ETHAN - ET for Male BC

This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer. The drugs used in this study are: * Tamoxifen * Anastrozole * Degarelix * Abemaciclib

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Jose Pablo LeoneUpdated: Apr 30, 2026Locations: 8
Eligibility criteria

Men aged 18 years or older, with diagnosis of invasive breast cancer who have no... [+19]

Prior endocrine therapy, chemotherapy, radiation therapy, or investigational the... [+6]

Status: Not yet recruiting

Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2

This is an interventional, prospective, single-center study designed to collect and describe genetic, environmental and psychosocial control data from male participants. The participants did not have any prior history of cancer at the time of the oncogenetic consultation and do not have the family mutation researched during the oncogenetic consultation (targeted genetic testing). The participants are referenced in the IUCT-O medical records as family members of patients suffering from male breast cancer. The study will be conducted on a population of 120 participants.

Participants needed: 120
Trial details
Age: 66+Biological sex: MaleType: InterventionalSponsor: Institut Claudius RegaudUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

1. A male volunteer participant with no personal history of cancer, registered i... [+6]

1. Patient who has forfeited his/her freedom by administrative or legal award or...